Transchem

Transchem Cash Conversion Cycle

The Cash Conversion Cycle (CCC) of Transchem (500422.BO) as of Oct 20, 2026 is -48.97. In the previous year, Cash Conversion Cycle (CCC) was 356.77 — a change of -113.73% (lower).

Cash Conversion Cycle

-48.97

YoY

-113.73%

Last updated:

Cash Conversion Cycle (CCC) of Transchem is 2026 -48.97 . Cash Conversion Cycle (CCC) of Transchem was 2025 356.77 . It decreases by -113.73% lower compared to the previous year.

The Transchem Cash Conversion Cycle history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion Cycle
Date
Cash Conversion Cycle
Jan 1, 2019
238.86 INR
Jan 1, 2020
46.90 INR
Jan 1, 2021
30.38 INR
Jan 1, 2022
64.63 INR
Jan 1, 2023
0.00 INR
Jan 1, 2024
365.00 INR
Jan 1, 2025
356.77 INR
Jan 1, 2026
-48.97 INR
The Transchem Cash Conversion Cycle history
YEARCash Conversion CycleYoY
-48.97-113.73%
356.77-2.25%
365.00—
0.00-100.00%
64.63+112.78%
30.38-35.23%
46.90-80.37%
238.86-99.56%
54,208.99+1.16%
53,584.90-97.82%
2.45 M+7,938.16%
30,533.70—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Transchem Stock analysis

What does Transchem do? Transchem Ltd is a pharmaceutical company based in Thane, India, operating within the Health Care sector. The company has been publicly traded since its IPO on January 27, 1993, with a ticker symbol of 500422.BO and ISIN code INE019B01010. Its headquarters are located in Thane, Maharashtra. Transchem Ltd is engaged in the production and processing of pharmaceutical products, though specific product details are not provided. The company's website is https://www.transchem.net/. While the source description mentions the company's involvement in mushroom production, this appears to be an unverified or incorrect detail, as the company is classified under the Pharmaceuticals industry. The source also states that the company temporarily invests funds in short-term treasury operations while seeking new business opportunities, but this information should be treated with caution as it is not confirmed by official company sources. The company's primary focus remains on pharmaceutical manufacturing and processing within the Indian market. No additional details about its founding year, key personnel, acquisitions, or financial figures are provided in the available information. Transchem Ltd operates as a publicly listed entity on the Bombay Stock Exchange, though specific market capitalization or trading volume data is not included in the given facts. The company's activities are centered around pharmaceutical production, with no indication of other significant business lines beyond those related to the Health Care sector. Transchem is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Transchem stock

Cash Conversion Cycle (CCC) of Transchem is -48.97 in 2026.

Cash Conversion Cycle (CCC) of Transchem changed from 356.77 to -48.97, representing a -113.73% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Cycle (CCC) Transchem since 2006 – with annual values, charts, and detailed analysis.

The Cash Conversion Cycle measures how long it takes to convert inventory investments into cash from sales. A shorter CCC indicates more efficient working capital management.

CCC = DSO + DIO - DPO

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Cycle (CCC)'s Transchem with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Cycle (CCC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Cycle (CCC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Transchem

All Key Metrics — Transchem